Clinical Trial Update: A Study to Investigate OCS Tapering in Adult Participants With Generalized Myasthenia Gravis Treated With Ravulizumab [Phase 4]

View source ↗

Summary

Phase 4 trial investigating tapering of oral corticosteroids in adults with generalized myasthenia gravis who are treated with ravulizumab; recruitment is ongoi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Generalized Myasthenia Gravis

Drugs mentioned

• ULTOMIRIS (ravulizumab)

Snippet

Sponsor: Alexion Pharmaceuticals, Inc. | Conditions: Generalized Myasthenia Gravis, gMG | Phase 4 | Status: RECRUITING